Published

Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of chromatography. B, Biomedical sciences and applications
Date: 2000-10-01
Source: PubMed
DOI: 10.1016/s0378-4347(00)00461-8
PubMed: 11092582

Authors

Bogusz MJ

Watch author

Derived topics and classifications

psilocybin psilocin Addiction Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 9 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis2020-03-29 Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol2013-08-01 Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS2013-05-01 A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability2012-11-01 Liquid Chromatography-Mass Spectrometric and Liquid Chromatography-Tandem Mass Spectrometric Determination of Hallucinogenic Indoles Psilocin and Psilocybin in “Magic Mushroom” Samples2005-03-01 Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry2004-12-01 Development of a psilocin immunoassay for serum and blood samples2004-12-01 Concise Large-Scale Synthesis of Psilocin and Psilocybin, Principal Hallucinogenic Constituents of “Magic Mushroom”2003-06-01 Synthesis of a psilocin hapten and a protein-hapten conjugate2002-09-01

Related papers

Psychedelic-assisted therapy: An overview for the internist.Cleveland Clinic journal of medicine · 2025-03-03 Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocinArchives of Toxicology · 2026-08-01 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderClinicalTrials.gov · 2026-06-29 Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy.Psychedelic medicine (New Rochelle, N.Y.) · 2026-06-01 Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-15